Age 65–74 (n = 298) | Age 75+ (n = 73) | p Value | |
---|---|---|---|
Central neck recurrence | 12 (4%) | 6 (8.2%) | 0.135 |
Lateral recurrence | 11 (3.6%) | 4 (5.4%) | 0.486 |
Histologic Features: | |||
• Mean tumor size (mm) | 17 ± 11 | 22 ± 5 | 0.513 |
• Microcarcinoma | 98 (32.8%) | 16 (21.9%) | 0.068 |
• Unifocal | 276 (92.6%) | 62 (84.9%) | < 0,001* |
• Multifocal | 22 (7.3%) | 11 (15%) | < 0,001* |
pTNM stage | |||
• I | 280 (93.9%) | 54 (73.9%) | < 0.001* |
• II | 15 (5%) | 12 (16.4%) | < 0.001* |
• III | 3 (1%) | 7 (9.5%) | < 0.001* |
Complications (All patients) | |||
• Temporary hypoparathyroidism | 34 (11.4%) | 18 (24.6%) | 0.003* |
• Permanent hypoparathyroidism | 1 (0.33%) | 2 (2.7%) | 0.039* |
• Recurrent nerve injury | 6 (2%) | 7 (9.5%) | 0.001* |
Complications (Group A - TT) | |||
• Temporary hypoparathyroidism | 12/152 (7,8%) | 6/32 (18,7%) | 0.060 |
• Permanent hypoparathyroidism | 0/152 (0%) | 0/32 (0%) | NA |
• Recurrent nerve injury | 2/152 (1,3%) | 3/32 (9,7%) | 0.010* |
Complications (Group B – TT+ PCLD) | |||
• Temporary hypoparathyroidism | 22/146 (15%) | 12/41 (29,2%) | 0.037 |
• Permanent hypoparathyroidism | 1/146 (0,6%) | 2/41 (4,8%) | 0.059 |
• Recurrent nerve injury | 4/146 (2,7%) | 4/41 (9,7%) | 0.049* |